Nuclear Engineering and Technology

Korean Nuclear Society (한국원자력학회)
권호 표지
DOI QR코드

DOI QR Code

Application of the new ICRP iodine biokinetic model for internal dosimetry in case of thyroid blocking

  • Kwon, Tae-Eun (National Radiation Emergency Center, Korea Institute of Radiological and Medical Sciences) ;
  • Chung, Yoonsun (Department of Nuclear Engineering, Hanyang University) ;
  • Ha, Wi-Ho (National Radiation Emergency Center, Korea Institute of Radiological and Medical Sciences) ;
  • Jin, Young Woo (National Radiation Emergency Center, Korea Institute of Radiological and Medical Sciences)
  • Received : 2019.08.17
  • Accepted : 2020.01.29
  • Published : 2020.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

Administration of stable iodine has been considered a best measure to protect the thyroid from internal irradiation by radioiodine intake, and its efficacy on thyroid protection has been quantitatively evaluated in several simulation studies on the basis of simple iodine biokinetic models (i.e., three-compartment model). However, the new iodine biokinetic model adopted by the International Commission on Radiological Protection interprets and expresses the thyroid blocking phenomenon differently. Therefore, in this study, the new model was analyzed in terms of thyroid blocking and implemented to reassess the protective effects and to produce dosimetric data. The biokinetic model calculation was performed using computation modules developed by authors, and the results were compared with those of experimental data and prior simulation studies. The new model predicted protective effects that were generally consistent with those of experimental data, except for those in the range of stable iodine administration -72 h before radioiodine exposure. Additionally, the dosimetric data calculated in this study demonstrates a critical limitation of the three-compartment model in predicting bioassay functions, and indicated that dose assessment 1 d after exposure would result in a similar dose estimate irrespective of the administration time of stable iodine.

Keywords

References

  1. World Health Organization, Iodine Thyroid Blocking: Guidelines for Use in Planning for and Responding to Radiological and Nuclear Emergencies, 2017. ISBN 9789241550185.
  2. P. Verger, A. Aurengo, B. Geoffroy, B. Le Guen, Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: a review, Thyroid 11 (4) (2001) 353-360. https://doi.org/10.1089/10507250152039082
  3. D. Ramsden, F.H. Passant, C.O. Peabody, R.G. Speight, Radioiodine uptakes in the thyroid. Studies of the blocking and subsequent recovery of the gland following the administration of stable iodine, Health Phys. 13 (6) (1967) 633-646. https://doi.org/10.1097/00004032-196706000-00012
  4. R. Wootton, B.J. Hammond, A computer simulation study of optimal thyroid radiation protection during investigations involving the administration of radioiodine-labelled pharmaceuticals, Br. J. Radiol. 51 (604) (1978) 265-272. https://doi.org/10.1259/0007-1285-51-604-265
  5. M. Jang, H.K. Kim, C.W. Choi, C.S. Kang, Age-dependent potassium iodide effect on the thyroid irradiation by 131I and 133I in the nuclear emergency, Radiat. Protect. Dosim. 130 (4) (2008) 499-502. https://doi.org/10.1093/rpd/ncn068
  6. P.B. Zanzonico, D.V. Becker, Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout, Health Phys. 78 (6) (2000) 660-667. https://doi.org/10.1097/00004032-200006000-00008
  7. D. Broggio, P. Teles, T. Vrba, V. Berkovskyy, Assessment from in vivo measurements of thyroid dose due to iodine-131 inhalation when stable iodine has been administered, Radiat. Meas. 127 (2019) 106144. https://doi.org/10.1016/j.radmeas.2019.106144
  8. R.W. Leggett, A physiological systems model for iodine for use in radiation protection, Radiat. Res. 174 (4) (2010) 496-516. https://doi.org/10.1667/RR2243.1
  9. International Commission on Radiological Protection, Occupational intakes of radionuclides: Part 3, ICRP (Int. Comm. Radiol. Prot.) Publ. 137 (3-4) (2017) 46, 1-486.
  10. International Commission on Radiological Protection, Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances, ICRP (Int. Comm. Radiol. Prot.) Publ. 128 (44) (2015) 7-321 (2_suppl).
  11. T.E. Kwon, M. Park, J.K. Kang, M. Cho, S. Jang, J.M. Kim, W.H. Ha, Y.W. Jin, Internal dose assessment after 131I-iodide misadministration in a patient with incompletely blocked thyroid uptake: personalized internal dose assessment by estimating individual-specific biokinetics, Health Phys. 116 (6) (2019) 760-770. https://doi.org/10.1097/hp.0000000000001019
  12. T.E. Kwon, M. Park, G.H. Jung, Y. Chung, W.H. Ha, Y.W. Jin, Practical methods for internal dose assessment for radioiodine intake after thyroid blocking: classification of degree of blockage and determination of insensitive measurement point, Radiat. Protect. Dosim. (2019), https://doi.org/10.1093/rpd/ncz139.
  13. J. Wolff, Iodide goiter and the pharmacologic effects of excess iodide, Am. J. Med. 47 (1) (1969) 101-124. https://doi.org/10.1016/0002-9343(69)90245-9
  14. M. Blum, M. Eisenbud, Reduction of thyroid irradiation from 131-I by potassium iodide, J. Am. Med. Assoc. 200 (12) (1967) 1036-1040. https://doi.org/10.1001/jama.1967.03120250070012
  15. International Commission on Radiological Protection, Human alimentary tract model for radiological protection, ICRP publication 100, Ann. ICRP 36 (1-2) (2006).
  16. International Commission on Radiological Protection, Human respiratory tract model for radiological protection, ICRP publication 66, Ann. ICRP 24 (1-3) (1994).
  17. International Commission on Radiological Protection, The ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions. ICRP Publication 133, Ann. ICRP 45 (2) (2016) 1-74. https://doi.org/10.1177/0146645316640446
  18. International Commission on Radiological Protection, Adult reference computational phantoms. ICRP publication 110, Ann. ICRP 39 (2) (2009).
  19. International Commission on Radiological Protection, The 2007 recommendations of the international commission on radiological protection. ICRP publication 103, Ann. ICRP 37 (2-4) (2007).
  20. E. Sternthal, L. Lipworth, B. Stanley, C. Abreau, S.L. Fang, L.E. Braverman, Suppression of thyroid radioiodine uptake by various doses of stable iodide, N. Engl. J. Med. 303 (19) (1980) 1083-1088. https://doi.org/10.1056/NEJM198011063031903
  21. D. Koutras, D. Livadas, The minimum dose of potassium iodide which inhibits the thyroidal radioiodine uptake, Nucl. Med. 5 (1966) 256-261.
  22. A.E. Johnson, The rate of return of radioiodine uptake by the normal thyroid after suppression by pharmacological doses of stable iodide, Health Phys. 9 (1963) 537-538. https://doi.org/10.1097/00004032-196305000-00009
  23. H. Hanscheid, C. Reiners, G. Goulko, M. Luster, M. Schneider-Ludorff, A.K. Buck, M. Lassmann, Facing the nuclear threat: thyroid blocking revisited, J. Clin. Endocrinol. Metab. 96 (11) (2011) 3511-3516. https://doi.org/10.1210/jc.2011-1539
  24. International Commission on Radiological Protection, Radiation dose to patient from radiopharmaceuticals. ICRP Publication 53, Ann. ICRP 18 (1-4) (1988).